Armed Forces News

A former Navy aviator says that an experimental medication that has not yet been approved by the Food and Drug Administration (FDA) is easing adverse symptoms of ALS — commonly known as Lou Gehrig’s disease. Bloomberg News reported that Matt Bellina, of Pennsylvania, believes he is stronger, can speak and swallow better and has greater lung capacity since he began a therapy protocol that includes a treatment called NurOwn.
The treatment is in final stages of FDA approval. In the past, such protocols would be unavailable for patients like Bellina until it is cleared for use. Last year, however, Congress passed a law that expedited delivery of experimental therapies such as NurOwn to people like Bellina, who might not be able to wait until the FDA acts. The law applies only to therapies that show distinct signs that they will work, and leaves intact the FDA’s ability to prevent sham artists from thrusting bogus “cures” upon patients that would ultimately do them no good.